1. Home
  2. KMDA vs FPH Comparison

KMDA vs FPH Comparison

Compare KMDA & FPH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • KMDA
  • FPH
  • Stock Information
  • Founded
  • KMDA 1990
  • FPH 2009
  • Country
  • KMDA Israel
  • FPH United States
  • Employees
  • KMDA N/A
  • FPH N/A
  • Industry
  • KMDA Biotechnology: Pharmaceutical Preparations
  • FPH Real Estate
  • Sector
  • KMDA Health Care
  • FPH Finance
  • Exchange
  • KMDA Nasdaq
  • FPH Nasdaq
  • Market Cap
  • KMDA 349.1M
  • FPH 338.2M
  • IPO Year
  • KMDA N/A
  • FPH 2017
  • Fundamental
  • Price
  • KMDA $6.47
  • FPH $5.06
  • Analyst Decision
  • KMDA Strong Buy
  • FPH
  • Analyst Count
  • KMDA 3
  • FPH 0
  • Target Price
  • KMDA $14.67
  • FPH N/A
  • AVG Volume (30 Days)
  • KMDA 106.2K
  • FPH 157.3K
  • Earning Date
  • KMDA 05-07-2025
  • FPH 04-24-2025
  • Dividend Yield
  • KMDA 3.10%
  • FPH N/A
  • EPS Growth
  • KMDA 66.67
  • FPH 25.45
  • EPS
  • KMDA 0.25
  • FPH 0.96
  • Revenue
  • KMDA $160,953,000.00
  • FPH $237,926,000.00
  • Revenue This Year
  • KMDA $14.01
  • FPH N/A
  • Revenue Next Year
  • KMDA $9.24
  • FPH N/A
  • P/E Ratio
  • KMDA $25.58
  • FPH $5.08
  • Revenue Growth
  • KMDA 12.93
  • FPH 12.37
  • 52 Week Low
  • KMDA $4.74
  • FPH $2.83
  • 52 Week High
  • KMDA $9.15
  • FPH $6.71
  • Technical
  • Relative Strength Index (RSI)
  • KMDA 49.43
  • FPH 48.96
  • Support Level
  • KMDA $6.36
  • FPH $4.80
  • Resistance Level
  • KMDA $6.57
  • FPH $5.04
  • Average True Range (ATR)
  • KMDA 0.28
  • FPH 0.26
  • MACD
  • KMDA 0.06
  • FPH 0.01
  • Stochastic Oscillator
  • KMDA 76.23
  • FPH 63.16

About KMDA Kamada Ltd.

Kamada Ltd is a drug-focused, plasma-derived protein therapeutics company. It is involved in the business of developing, producing, and marketing specialty therapeutics using protein purification proprietary technology. Its product portfolio consists of Glassia, Bramitob, Foster, Ixiaro, Factor-IX, and others. The company has two segments namely, the Proprietary Products segment and the Distribution segment. It derives the majority of its revenue from the Proprietary products segment. The firm categorizes its products in Lung Disease, Vaccines, Haemophilia, Immunoglobulins, Critical care, and Diagnostics.

About FPH Five Point Holdings LLC

Five Point Holdings LLC is an owner and developer of mixed-use, master-planned communities in California. It is engaged in developing new communities that, in addition to homesites, include commercial, retail, educational, and recreational elements, as well as civic areas, parks, and open spaces. Its three reportable segments are Valencia, San Francisco, and Great Park. It derives the majority of revenue from the Great Park segment which includes Great Park Neighborhoods being developed adjacent to and around the Orange County Great Park, a metropolitan park under construction in Orange County, California.

Share on Social Networks: